• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Novabay Pharmaceuticals Inc

+ Add to Watchlist


0.7600 USD 0.0140 1.88%

As of 20:04:05 ET on 09/17/2014.

Snapshot for Novabay Pharmaceuticals Inc (NBY)

Open: 0.7300 Day's Range: 0.7300 - 0.7750 Volume: 237,928
Previous Close: 0.7460 52wk Range: 0.6900 - 2.0300 1-Yr Rtn: -55.81%

Stock Chart for NBY

No chart data available.
  • NBY:US 0.7600
  • 1D
  • 1M
  • 1Y
Interactive NBY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NBY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7464
Est. EPS (USD) (12/2014) -0.2930
Est. PEG Ratio -
Market Cap (M USD) 38.59
Shares Outstanding (M) 50.78
30 Day Average Volume 497,364
Price/Book (mrq) 8.3696
Price/Sale (ttm) 3.7438
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NBY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NBY

Novabay Pharmaceuticals Inc. is a biopharmaceutical company. The Company develops product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. Novabay Pharmaceuticals Inc. has developed a class of antimicrobial compounds for use in the treatment and prevention of bacterial infections.

Ramin Najafi "Ron"Chairman/President/CEOThomas J PaulsonCFO/Treasurer/Secretary
Roy J WuSenior VP:Bus & Corp DevDavid W StromanSenior VP:Ophthalmic Product Dev
More Company Profile & Key Executives for NBY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil